Position in ICLR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$11,259,882
+$2,119,727 QoQ
Shares Held
64,820
+29.2% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
2.11%
of 13F equity value
Holder Rank
#92
of 422 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Derivatives in ICLR
reported options exposure · as of Jun 30, 2026CallValue
$12,159,700
CallShares
70,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Arvin Capital Management LP holds $60,838,789 across 3 Diagnostics & Research names. ICLR ranks #3 (18.5% of the industry book) .
All Filings in ICLR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,159,700 | 70,000 | Call | Sole | 2026-08-13 | |
| 2026-06-30 | $11,259,882 | 64,820 | Shares | Sole | 2026-08-13 | |
| 2025-12-31 | $382,662 | 2,100 | Call | Sole | 2026-02-13 | |
| 2025-12-31 | $9,140,155 | 50,160 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,543,125 | 71,675 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||